TY - JOUR
AU - Szumita, Paul M.
AB - Objective:To evaluate the cost, workflow, and safety of implementing a vial transfer device system.Methods:In this retrospective analysis, pharmacy systems and electronic health record reports identified high-volume and high-cost medications prepared by a Vial2Bag® (V2B) system from July 2017 to June 2018. The major outcome was the extrapolated yearly cost avoidance (EYCA) from utilization of a V2B system, calculated by subtracting total costs of the V2B system from total cost of ready-to-use products and locally compounded sterile products. Secondary outcomes included a workflow and safety analysis.Results:Implementing a V2B system led to a total EYCA of $2 295 261. A total of 283 209 potential V2B units were available for dispensing from automated dispensing systems and 41 082 yearly sterile product room units were avoided. A 0.02% safety report incidence per V2B administration was calculated at our institution.Conclusion:Use of a V2B system resulted in a substantial cost avoidance compared to purchasing commercial products and preparing locally compounded sterile products. The V2B system appears to be a safe addition to further optimize workflow but may require further investigation in prospective analyses.
TI - Evaluation of Cost, Workflow, and Safety of Implementing a Vial Transfer Device for Ready-to-Mix Drugs at an Academic Medical Center
JO - Journal of Pharmacy Practice
DO - 10.1177/0897190020938195
DA - 2021-12-01
UR - https://www.deepdyve.com/lp/sage/evaluation-of-cost-workflow-and-safety-of-implementing-a-vial-transfer-S7fxnSMHtz
SP - 908
EP - 912
VL - 34
IS - 6
DP - DeepDyve
ER -